Ery-tab
NDC 42549-535
Product Information
Ery-tab is a ANDA-approved product labeled by Stat Rx Usa Llc. Erythromycin is used to treat a wide variety of bacterial infections. It is supplied as a white product. This product entry covers the primary NDC 42549-535 and its associated package configuration. This profile includes active and inactive ingredient UNII references and FDA labeling data.
Primary Identification
Labeler & Regulatory Data
Marketing Timeline
Product Characteristics
EH
Code Structure Chart
Product Details
What is NDC 42549-535?
What are the uses of this product?
Which are the associated UNII Codes?
The UNII codes for the active ingredients in this product are:
- ERYTHROMYCIN (UNII: 63937KV33D)
- ERYTHROMYCIN (UNII: 63937KV33D) (Active Moiety)
Which are the Inactive Ingredients associated UNII Codes?
The inactive ingredients are all the component of a medicinal product OTHER than the active ingredient(s). The acronym "UNII" stands for “Unique Ingredient Identifier” and is used to identify each inactive ingredient present in a product. The UNII codes for the inactive ingredients in this product are:
- SILICON DIOXIDE (UNII: ETJ7Z6XBU4)
- CROSCARMELLOSE SODIUM (UNII: M28OL1HH48)
- CROSPOVIDONE (UNII: 68401960MK)
- DIACETYLATED MONOGLYCERIDES (UNII: 5Z17386USF)
- HYDROXYPROPYL CELLULOSE (UNII: RFW2ET671P)
- HYPROMELLOSES (UNII: 3NXW29V3WO)
- HYPROMELLOSE PHTHALATE (24% PHTHALATE, 55 CST) (UNII: 87Y6436BKR)
- MAGNESIUM STEARATE (UNII: 70097M6I30)
- CELLULOSE, MICROCRYSTALLINE (UNII: OP1R32D61U)
- POVIDONE (UNII: FZ989GH94E)
- PROPYLENE GLYCOL (UNII: 6DC9Q167V3)
- SODIUM CITRATE (UNII: 1Q73Q2JULR)
- SORBITAN MONOOLEATE (UNII: 06XEA2VD56)
- TALC (UNII: 7SEV7J4R1U)
- TITANIUM DIOXIDE (UNII: 15FIX9V2JP)
What is the NDC to RxNorm Crosswalk for this product?
- RxCUI: 206078 - ERY-TAB 333 MG Delayed Release Oral Tablet
- RxCUI: 206078 - erythromycin 333 MG Delayed Release Oral Tablet [Ery-Tab]
- RxCUI: 206078 - Ery-Tab 333 MG Delayed Release Oral Tablet
- RxCUI: 315090 - erythromycin 333 MG Delayed Release Oral Tablet
* Please review the full disclaimer at the bottom of this page.